endocrine:drugs:prednisolone
Prednisolone
Classification
- Intermediate-acting systemic glucocorticoid
- Active metabolite of prednisone
Parent class:
Mechanism of Action
Binds intracellular glucocorticoid receptor → alters gene transcription → suppresses inflammatory cytokines and immune activation.
See:
Equivalent anti-inflammatory mechanism to Prednisone.
Key Distinction
Prednisone = prodrug Prednisolone = active form
Prednisolone does NOT require hepatic activation.
Preferred in:
- Severe hepatic impairment
- Pediatric liquid formulations
Clinical Uses
- Asthma exacerbations
- Autoimmune disease
- Severe allergic reactions
- Inflammatory disorders
Adverse Effects
Short-term:
- Hyperglycemia
- Mood changes
- Insomnia
Long-term:
- HPA suppression
- Osteoporosis
- Cushingoid features
- Immunosuppression
Clinical Pearls
- Same potency and duration as prednisone.
- Preferred in patients with significant liver disease.
- Liquid form commonly used in pediatrics.
- Taper required with prolonged therapy.
endocrine/drugs/prednisolone.txt · Last modified: by andrew2393cns
